IL2 and myocardial infarction: Exogenous infusion of low-dose IL-2 that significantly expands the ILC2 population improves cardiac function not only in mice but also in humans, suggesting that administration of the cytokine could be a novel therapeutic strategy for avoiding progression to heart failure in patients with MI.